The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post Navigating Updated FDA IND Safety Reporting Guidance WCG Q&A: Should you trust trending peptide injections? FDA moves toward easing restrictions on certain peptides BioPharma Dive